Peer-influenced content. Sources you trust. No registration required. This is HCN.
The New England Journal of Medicine
Chronic insomnia affects about 10% of adults and is associated with increased risks of major depression, hypertension, Alzheimer’s disease, and work disability.
Family Medicine/General Practice July 23rd 2024
Practical Neurology
Kisunla’s approval introduces a novel treatment option for early Alzheimer’s disease, potentially altering the landscape of AD management with its ability to significantly reduce amyloid plaque levels and slow cognitive decline.
Neurology July 17th 2024
MDLinx
Recent research suggests that promoting neuroplasticity through various techniques may offer new treatment possibilities for patients with neurodegenerative diseases, developmental disorders, and mental health conditions.
AL amyloidosis presents a diagnostic challenge due to its varied symptoms, but advancements in therapeutic options, including CyBorD plus daratumumab and emerging antifibril monoclonal antibodies, offer hope for better patient management.
Cardiology July 9th 2024
This article poses questions surrounding the ethical challenges in brain research, highlighting the need for post-trial care responsibilities and privacy protections as neurotechnologies advance.
Neurology July 3rd 2024
Chiari malformation type 1 is marked by cerebellar tonsils descending below the foramen magnum, often causing headaches, paresthesia, and CSF flow obstruction. Early diagnosis and appropriate surgical intervention can significantly improve patient outcomes.